Olema Pharmaceuticals, Inc. (OLMA)

NASDAQ: OLMA · Real-Time Price · USD

4.110

-0.090 (-2.14%)

At close: Mar 28, 2025, 4:00 PM

4.214

+0.104 (2.54%)

After-hours: Mar 28, 2025, 5:14 PM EDT

Olema Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2018
Selling, General & Admin	17.74	18.82	24.71	20.39	7.82	Upgrade
Research & Development	124.52	86.14	82.27	51.1	13.7	Upgrade
Operating Expenses	142.26	104.96	106.99	71.49	21.53	Upgrade
Operating Income	-142.26	-104.96	-106.99	-71.49	-21.53	Upgrade
Interest Expense	-	-	-	-	-0.65	Upgrade
Interest & Investment Income	12.68	8.33	2.23	0.44	0.06	Upgrade
Other Non Operating Income (Expenses)	0.1	-0.02	-0.03	-0.05	-	Upgrade
Pretax Income	-129.47	-96.66	-104.79	-71.1	-22.12	Upgrade
Net Income	-129.47	-96.66	-104.79	-71.1	-22.12	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	-	1.87	Upgrade
Net Income to Common	-129.47	-96.66	-104.79	-71.1	-23.99	Upgrade
Shares Outstanding (Basic)	59	45	40	40	7	Upgrade
Shares Outstanding (Diluted)	59	45	40	40	7	Upgrade
Shares Change (YoY)	29.83%	13.13%	1.19%	462.91%	170.75%	Upgrade
EPS (Basic)	-2.20	-2.14	-2.62	-1.80	-3.42	Upgrade
EPS (Diluted)	-2.20	-2.14	-2.62	-1.80	-3.42	Upgrade
Free Cash Flow	-104.51	-83.73	-82.43	-52.27	-19.92	Upgrade
Free Cash Flow Per Share	-1.78	-1.85	-2.06	-1.32	-2.84	Upgrade
EBITDA	-141.87	-104.58	-106.63	-71.33	-21.52	Upgrade
D&A For EBITDA	0.39	0.38	0.36	0.16	0.01	Upgrade
EBIT	-142.26	-104.96	-106.99	-71.49	-21.53	Upgrade

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q